A pharmaceutical company practitioner told reporters that previously, drugs and consumables "life and death" by the hospital staff in control, and give kickbacks, it is in the fierce competition in the top secret , a company sent, other companies also want to immediately! , slowly, we began to compete for the relevant personnel to transport the interests of the good relations with them, in exchange for the sale of drugs to use the priority, and ultimately the formation of a vicious circle.
These "deals" not only create problems of overuse of medication, over-checking, and over-use of high-value medical supplies, but also shift the high kickbacks to patients through high drug prices, increasing their burden of care.
The person in charge of the Office of Centralized Purchasing and Use of Joint Purchasing of Drugs of State Organizations said, "From the absolute price level, a considerable portion of the price of medicines for a long time there is an inflated water, some generic drug price level is higher than the international price of more than two times, the circulation costs account for the main part of the price."
In response, many patients said it was difficult to accept. Ms. Sun from Anhui said, "A few years ago, I went to the hospital, a common cold was prescribed hundreds of dollars of medicine, and finally I did not take the medicine, directly away."
Mr. Fu of Chongqing confessed, "The cost of seeing a doctor has actually been decreasing over the years, but too many kickbacks have come to light before, and as soon as I come across a high-priced drug, I still can't help but wonder if there is something 'cats and dogs' in it."
Extended information
Reasons why it is difficult to eradicate pharmaceutical bribery:
A number of industry experts said that the centralization of power and the lack of effective supervision is the most direct reason. In the previous chain of circulation of medicine, the hospital departments are from the production of drugs to enter the pharmacy of the "road", the relevant staff have the absolute right to speak.
A practitioner also said: "the key positions and key links of the integrity risk prevention and control of insufficient attention, supervision and formality, is a common problem in the medical system."
In addition to this, the previous "recruitment and procurement separation" of the drug procurement model is also one of the reasons for the ban on pharmaceutical bribery. The National Development and Reform Commission (NDRC) issued the Opinions on Further Rectifying the Order of Prices in the Drug and Medical Service Markets in 2006, which stipulated that medical institutions in counties and above could charge a 15% markup on the sale of drugs.
With the continued deepening of the reform of the pharmaceutical and healthcare system, the markup on medicines has now been completely abolished. Although the rate of drug retail markup has been strictly limited, due to the decentralized procurement model, there are only recruiting price without volume, volume and price decoupling, the lack of sales volume expectations of enterprises, in order to obtain a higher income, often take the initiative to bribe hospitals to make the winning bid price higher.
China Youth Network - Commission for Discipline Inspection exposure of pharmaceutical bribery cases more than half of the country's top 100 pharmaceutical companies have kickbacks